Adline Chem Lab Ltd.
BSE: ADLINE
Prev Close
16.85
Open Price
16.52
Volume
100
Today Low / High
16.52 / 16.52
52 WK Low / High
9.4 / 22.25
Range
16 - 17
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 16.52, reflecting a change of -0.33 (-1.95846%). The expected target range on the BSE is 16 - 17. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Adline Chem Lab Ltd. Graph
Adline Chem Lab Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Adline Chem Lab Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 16.52, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 16.52 | 16.69 | 15.02 - 18.35 |
| 16.85 | 13.48 - 20.22 | ||
| 17.02 | 11.91 - 22.12 | ||
| Bearish Scenario | 16.52 | 16.35 | 14.72 - 17.99 |
| 16.19 | 12.95 - 19.43 | ||
| 16.02 | 11.22 - 20.83 |
Overview of Adline Chem Lab Ltd.
ISIN
INE276T01018
Industry
Medical - Pharmaceuticals
Vol.Avg
263
Market Cap
96,642,000
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
No financial ratio data available.
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial income report data available. | |||||||||||
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial balance sheet data available. | ||||||||||||
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial cash flow statement data available. | |||||||||||
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial income report data available. | |||||||||
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial balance sheet data available. | |||||||||
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹874.35 | ₹104,654,300,261.00 | ₹103,212.00 |
Key Executives
Gender: male
Year Born: 1989
Gender: male
Year Born:
FAQs about Adline Chem Lab Ltd.
The CEO is Kuldip Ashok Kumar Parekh.
The current price is ₹16.52.
The range is ₹9.4-22.25.
The market capitalization is ₹9.66 crores.
The company operates in the Healthcare sector.
Overview of Adline Chem Lab Ltd. (ISIN: INE276T01018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹9.66 crores and an average daily volume of 263 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.